COVID-19: Reasons to discourage off-label drug treatmentsRandomized controlled trials are the only way to find effective and safe treatments for COVID-19 How our team isolated the new coronavirusI study viruses—here's how we've been helping fight the pandemic CSHP considers full membership for techs Techs a fast-growing segment at NLPB Ottawa doubles number of funded coronavirus research projects Coronavirus: Canada's response hits a turning point Due to the speed at which COVID-19 spreads, we need to move beyond learning about the risk and start putting an operational plan in place One in five Canadians think COVID-19 pandemic blown out of proportion: poll The poll suggests that 18- to 34-year-olds were most likely to think the crisis is overblown Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidence Pharmacy and medical organizations issue statements to discourage off-label prescribing Dire scenario for intensive care even if COVID-19 infection rate drops: study That scenario assumes the average daily rate of infections over 37 days would be 7.5% compared with the 26% daily rate that Canada has experienced recently COVID-19 drug therapy options: An update No therapies have been proven effective for preventing or treating COVID-19; however, there are some promising options First Previous 252 253 254 255 256 Next Last
